These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 525994)
1. Ceftizoxime (FK 749), a new parenteral cephalosporin: in vitro and in vivo antibacterial activities. Kamimura T; Matsumoto Y; Okada N; Mine Y; Nishida M; Goto S; Kuwahara S Antimicrob Agents Chemother; 1979 Nov; 16(5):540-8. PubMed ID: 525994 [TBL] [Abstract][Full Text] [Related]
2. Comparison of antibacterial activity of a new cephalosporin, ceftizoxime (FK 749) with other cephalosporin antibiotics. Nishida M; Kamimura T; Okada N; Matsumoto Y; Mine Y; Murakawa T; Goto S; Kuwahara S J Antibiot (Tokyo); 1979 Dec; 32(12):1319-27. PubMed ID: 317284 [TBL] [Abstract][Full Text] [Related]
3. Enterobacter cloacae outer membrane permeability to ceftizoxime (FK 749) and five other new cephalosporin derivatives. Kojo H; Shigi Y; Nishida M J Antibiot (Tokyo); 1980 Mar; 33(3):317-21. PubMed ID: 6247313 [TBL] [Abstract][Full Text] [Related]
4. Inhibitory and bactericidal activity of cefmetazole and seven other beta-lactams against different bacterial inocula. Esposito S; Galante D; Barba D Chemioterapia; 1986 Apr; 5(2):101-4. PubMed ID: 3518963 [TBL] [Abstract][Full Text] [Related]
5. Antibacterial activity of ceftizoxime (FK 749), a new cephalosporin, against cephalosporin-resistant bacteria, and its stability to beta-lactamase. Kojo H; Nishida M; Goto S; Kuwahara S Antimicrob Agents Chemother; 1979 Nov; 16(5):549-53. PubMed ID: 316684 [TBL] [Abstract][Full Text] [Related]
6. Laboratory evaluation of ceftizoxime, a new parenteral cephalosporin. Kamimura T; Matsumoto Y; Shigi Y; Nishida M Arzneimittelforschung; 1980; 30(10):1662-4. PubMed ID: 6969078 [TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo antibacterial properties of FK 027, a new orally active cephem antibiotic. Kamimura T; Kojo H; Matsumoto Y; Mine Y; Goto S; Kuwahara S Antimicrob Agents Chemother; 1984 Jan; 25(1):98-104. PubMed ID: 6561017 [TBL] [Abstract][Full Text] [Related]
8. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli. Hall WH; Opfer BJ; Gerding DN Antimicrob Agents Chemother; 1980 Feb; 17(2):273-9. PubMed ID: 6247970 [TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo antibacterial activity of the new semisynthetic cephalosporin cefpirome. Mitsukude M; Inoue M; Mitsuhashi S Arzneimittelforschung; 1989 Jan; 39(1):26-30. PubMed ID: 2785801 [TBL] [Abstract][Full Text] [Related]
10. In vitro activities of moxalactam and cefotaxime against aerobic gram-negative bacilli. Jorgensen JH; Crawford SA; Alexander GA Antimicrob Agents Chemother; 1980 Jun; 17(6):937-42. PubMed ID: 6250470 [TBL] [Abstract][Full Text] [Related]
11. [The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics]. Miwatani T; Takeda Y; Kotera K; Nishimura T; Takashima T; Hiromatsu K; Tabuki K; Fujimoto S; Kamiki T; Yoshizaki E; Yabuuchi E; Shimizu Y; Matsunaga K; Yamanaka K; Furuta I; Iimori M; Kodama J; Tanaka M; Maejima K; Nukina M; Takashima E; Takahashi M; Harikane O; Masutani T Jpn J Antibiot; 1983 Feb; 36(2):260-76. PubMed ID: 6304368 [TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo antibacterial activities of FK037, a new parenteral cephalosporin. Nishino T; Otsuki M; Hatano K; Nishihara Y Chemotherapy; 1994; 40(3):167-82. PubMed ID: 8205935 [TBL] [Abstract][Full Text] [Related]
14. [Cefotetan, a new cephamycin antibiotic: in vitro and in vivo antibacterial activities (author's transl)]. Yano K; Suzaki K; Saito M; Toda M; Naito S; Ohmi Y Jpn J Antibiot; 1982 Feb; 35(2):438-59. PubMed ID: 6953260 [TBL] [Abstract][Full Text] [Related]
16. Cefpodoxime: comparative antibacterial activity, influence of growth conditions, and bactericidal activity. Knothe H; Shah PM; Eckardt O Infection; 1991; 19(5):370-6. PubMed ID: 1800379 [TBL] [Abstract][Full Text] [Related]
17. Multicentre comparative study on the antibacterial activity of FK-037, a new parenteral cephalosporin. Martínez-Beltrán J; Cantón R; Liñares J; García de Lomas J; Gimeno C; Tubau F; Baquero F Eur J Clin Microbiol Infect Dis; 1995 Mar; 14(3):244-52. PubMed ID: 7614970 [TBL] [Abstract][Full Text] [Related]
18. Antimicrobial activity of FK-037, a new broad-spectrum cephalosporin. International in vitro comparison with cefepime and ceftazidime. Frei R; Jones RN; Pignatari AC; Yamane N; Marco F; Hoban DJ Diagn Microbiol Infect Dis; 1994 Mar; 18(3):167-73. PubMed ID: 7924209 [TBL] [Abstract][Full Text] [Related]
19. [In vitro antibacterial activity of cefodizime (HR 221) on 323 hospital strains of Gram negative bacilli. Comparison with cefotiam, cefoperazone, cefotetan and cefotaxime]. Le Noc P; Bryskier A; Le Noc D Pathol Biol (Paris); 1985 May; 33(5):399-403. PubMed ID: 3897972 [TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin. Utsui Y; Inoue M; Mitsuhashi S Antimicrob Agents Chemother; 1987 Jul; 31(7):1085-92. PubMed ID: 3310868 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]